The effect of magnesium supplementation on vascular calcification in chronic kidney disease—a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale

INTRODUCTION: Chronic kidney disease (CKD) is associated with an increased risk of cardiovascular disease and mortality, which is thought to be caused by increased propensity towards vascular calcification (VC). Magnesium (Mg) inhibits phosphate-induced VC in vitro and in animal models and serum Mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Bressendorff, Iain, Hansen, Ditte, Schou, Morten, Kragelund, Charlotte, Brandi, Lisbet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726116/
https://www.ncbi.nlm.nih.gov/pubmed/28645983
http://dx.doi.org/10.1136/bmjopen-2017-016795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726116/
https://www.ncbi.nlm.nih.gov/pubmed/28645983
http://dx.doi.org/10.1136/bmjopen-2017-016795

Ejemplares similares